Tsuguhiro Kaneda - Concepedia

Author

Tsuguhiro Kaneda

Nagoya Medical Center

Also Known As

T Kaneda, Tsuguhiro KANEDA, Tsuguhiro Kaneda

Publications

696

Citations

H-Index

Concepts

All Affiliations

Nagoya Medical Center National Hospital Organization Nagoya Central Hospital Higashi Nagoya National Hospital Nagoya University

About

Tsuguhiro Kaneda is an author at Nagoya Medical Center specializing in hiv, aids pathogenesis, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	44
2	Epidemiology	2	2	29
3	Immunology	2	2	27
4	Engineering	1	1	17
5	Public Health	1	1	12

Tsuguhiro Kaneda

Publications

604

Citations

H-Index

Page 1

	Year	Citations
Distinguishing functional exosomes and other extracellular vesicles as a nucleic acid cargo by the anion‐exchange method Naohiro Seo, Junko Nakamura, Tsuguhiro Kaneda, Journal of Extracellular Vesicles	2022	61
A Simple HPLC Method for Simultaneous Determination of Lopinavir, Ritonavir and Efavirenz Yoshiko Usami, Tsuyoshi Oki, Masahiko Nakai, Chemical and Pharmaceutical Bulletin	2003	57
Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers Motohiro Senda, Akihiro Ito, Akiko Tsuchida, Biochemical Journal	2007	54
Detection of proliferative cells in dysplasia, carcinoma in situ, and invasive carcinoma of the uterine cervix by monoclonal antibody against DNA polymerase α Masafumi Mushika, Tadashi Miwa, Y Suzuoki, Cancer	1988	44
Production and characterization of monoclonal antibody against 10S DNA polymerase a from calf thymus Shigeo Masaki, Hiroshi Shiku, Tsuguhiro Kaneda, Nucleic Acids Research	1982	44
Determination of Plasma Tenofovir Concentrations Using a Conventional LC-MS Method Masaaki Takahashi, Yuichi Kudaka, Naoya Okumura, Biological and Pharmaceutical Bulletin	2007	44
Conventional HPLC Method Used for Simultaneous Determination of the Seven HIV Protease Inhibitors and Nonnucleoside Reverse Transcription Inhibitor Efavirenz in Human Plasma Masaaki Takahashi, Masao Yoshida, Tsuyoshi Oki, Biological and Pharmaceutical Bulletin	2005	40
Selection of Human Immunodeficiency Virus Type 1 Variants with an Insertion Mutation in the p6<sup>gag</sup> and p6<sup>pol</sup> Genes under Highly Active Antiretroviral Therapy Shiro Ibe, Naomi Shibata, Makoto Utsumi, Microbiology and Immunology	2003	36
The Validation of Plasma Darunavir Concentrations Determined by the HPLC Method for Protease Inhibitors Masaaki Takahashi, Yuichi Kudaka, Naoya Okumura, Biological and Pharmaceutical Bulletin	2007	32
No Observable Correlation between Central Nervous System Side Effects and EFV Plasma Concentrations in Japanese HIV Type 1-Infected Patients Treated with EFV Containing HAART Masaaki Takahashi, Shiro Ibe, Yuichi Kudaka, AIDS Research and Human Retroviruses	2007	32

Page 1